News
Stockhead on MSN
Tryptamine’s world-first psilocin based IV-infusion meets key objectives in phase 1b study
Tryptamine’s phase 1b study of IV-infused psilocin meets all objectives Lead asset TRP-8803 found safe at low, mid and upper ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback